The largest-ever clinical trial of a psychedelic drug will soon begin in Europe and North America. The drug is psilocybin - the active ingredient in magic mushrooms. The target is treatment-resistant depression.

27. Depression: The Psychedelic Cure | Katya Malievskaia & George Goldsmith

We dive deep into the science, tech, and social issues explored in the novel "After On." It's  NOT necessary to be an "After On" reader to listen, learn & enjoy this podcast!

Technology

Tech News

Podcasting

Gadgets

Software How-To

Science

Will the glittering dawn of the genai era be accompanied by a dark tsunami of pixel-perfect deep fakes? I discuss this prospect with Sam Harris, as well as the CEO of synthetic audio pioneer Resemble.ai.    

60: Deep Fakes | Sam Harris and Zohaib Ahmed

My thoughts on what's happening in the mad world of generative AI, announcing my new home online at robreid.substack.com, and more.

59: Generative AI | What’s New & What’s Next

USAID’s new “DEEP VZN” program aims to discover new pandemic-grade viruses, then broadcast their genomes to the world, according to MIT evolutionary engineer Kevin Esvelt. He estimates that 30,000 people in dozens of countries could then easily assemble them.

58: Recipes for Future Plagues | Kevin Esvelt

A wide-ranging discussion of cognition in octopuses & cuttlefish, plus many, many other topics with globally renowned sensory ecologist Roger Hanlon.

57: Octopus Intelligence (and more!) | Roger Hanlon

Harvard epidemiologist Megan Murray tells us all about the anti-tuberculosis vaccine “BCG,” and the astonishing protection it may provide against Covid -- as well as looming future pandemics.

27. Depression: The Psychedelic Cure | Katya Malievskaia & George Goldsmith

Download our free app to listen on your phone